期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 9, 期 9, 页码 901-906出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.8b00212
关键词
GPER; GPR30; estrogen receptor negative breast cancer; cAMP; GPCR; SERM
资金
- Saint Louis University
The G protein-coupled estrogen receptor (GPER, GPR30) represents a promising target for the treatment of estrogen receptor alpha and beta negative breast cancers. Previously reported agonists of GPER have shown that activation of GPER inhibits breast cancer cell proliferation. We report herein a new GPER agonist scaffold based upon in silico pharmacophore screening. Three of these compounds were found to increase cAMP at similar levels as the known GPER-selective agonist G-1. Compound 5 was found to be selective for GPER (over estrogen receptor alpha and beta) and inhibit breast cancer cell proliferation at levels consistent with G-1. Docking studies go on to suggest that both 5 and G-1 bind within the same binding pocket in GPER and point to possible key residues that are important in GPER activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据